The cells of most tissues in adults are significantly difficult to coax into life due to aging. However, Cameron Clockie, a renowned surgeon Canada has achieved this rare. Working at the University of Toronto, Dr. Clockie carved a name for himself as a pioneer of oral and maxillofacial tissues regeneration. His remarkable achievement marked a crucial step towards developing regenerative medicine for various diseases. Learn more about Cameron Clockie: https://www.dentevents.com/speaker-profile/dr-cameron–clokie/c12024915

Using his special skills and knowledge in cell longevity, he has successfully helped patients who have lost their jawbones by regenerating new jawbones, which are similar to the existing ones.

He achieved the milestones by inducing the cells from the patient’s chin to regenerate using a special protein. With the landmark surgery, Dr. Clockie has opened doors for new possibilities when it comes to regenerative medicine including a planned mandible reconstruction using tissues developed by regenerating hip bone cells.

Mastering Musculoskeletal Reconstruction in Canada

Cameron Clockie is a veteran in the dentistry industry with over decades of experience. He has dedicated his scholarly and professional life regenerative medicine with specialization in musculoskeletal reconstruction.

Cameron Clockie graduated from McGill University with a Bachelor of Science degree in 1981 before rejoining the university between 1981 and 1985 to study for Doctor of Dental Surgery degree. He also graduated from the university in 1990 with a Diploma in Oral and Maxillofacial Surgery and Doctor of Philosophy in 1992.

His strong academic background saw him serve in several organizations including professor of oral and maxillofacial surgery at University of Toronto. He held the position for over a decade before resigning in 2016. He previously worked at the university as an associate professor and departmental dean.

He has worked as a dental surgeon and associate dean at his alma mater. He has served as a board member for several institutions. Currently, he is focused on serving as the chief executive of Induce Biologics Inc., where has taken a leading role in helping the company develop regenerative medicine and solutions for patients suffering from musculoskeletal disorders. His scholarly commitment to the discipline has seen publish several peer-reviewed articles. He has also an inventor and scientist with over two dozen patents to his name.